Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;23(2):178-83.
doi: 10.1016/j.coi.2011.01.001. Epub 2011 Feb 1.

Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation

Affiliations
Review

Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation

G V Baracho et al. Curr Opin Immunol. 2011 Apr.

Abstract

Phosphoinositide 3-kinase (PI3K) defines a family of lipid kinases that direct a wide range of cellular processes and cell fate decisions. Since its discovery, and that of its enzymatic antagonist PTEN, much of the focus on PI3K has been on its oncogenic potential. In recent years, studies on PI3K signaling in B lymphocytes have established the importance of this pathway in effecting B cell differentiation and associated molecular events such as V(D)J recombination and class switch recombination. Intriguing new findings also indicate that there is specificity in the PI3K pathway in B cells, including preferential expression or usage of particular PI3K isoforms and counter-regulation by the PTEN and SHIP phosphatases. The role of PI3K adaptor proteins (CD19, BCAP, and TC21) has also undergone revision to reflect both shared and unique properties. The emergence of Foxo1 as a critical PI3K regulatory target for B cell differentiation has united membrane proximal regulatory events orchestrated by PI3K/PTEN/SHIP with key transcriptional targets. Insights into the regulation and impact of PI3K signaling have been brought to bear in new treatments for B cell malignancies, and will also be an important topic of consideration for B cell-dependent autoimmune diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1. PI3K signaling pathway in B cell development
Pro-B cell development is supported by IL-7 stimulation via the PI3K and STAT5 pathways. Weak PI3K signaling promotes retention of Foxo1 in the nucleus to drive Il7ra expression. PI3K signaling via the pre-BCR can be augmented by CD19 and countered by BLNK(SLP-65). Expression of pre-BCR components is repressed in an IRF4/IRF8-dependent manner to permit Foxo1-dependent expression of Rag in resting pre-B cells. Peripheral B cells require PI3K signaling to promote survival while Foxo1 activity is crucial for expression of Sell and Aicda, suggesting a dynamic balance for Foxo1 activity in peripheral B cell homeostasis and differentiation.

References

    1. Chen J, Limon JJ, Blanc C, Peng SL, Fruman DA. Foxo1 regulates marginal zone B-cell development. European Journal of Immunology. 2010;40:1890–1896. The authors show that loss of Foxo1 leads to enhanced marginal zone B cell formation and recovery of this population in CD19−/− mice, supporting the view that inactivation of Foxo1 is a critical component of CD19-dependent PI3K activation in this B cell subset.

    1. Denley A, Kang S, Karst U, Vogt PK. Oncogenic signaling of class I PI3K isoforms. Oncogene. 2007;27:2561–2574. - PubMed
    1. Kang S, Denley A, Vanhaesebroeck B, Vogt PK. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:1289–1294. - PMC - PubMed
    1. Carracedo A, Pandolfi PP. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008;27:5527–5541. - PubMed
    1. Leslie NR, Downes CP. PTEN: The down side of PI 3-kinase signalling. Cell Signal. 2002;14:285–295. - PubMed

Publication types

Substances